Olodanrigan
Olodanrigan Uses, Dosage, Side Effects, Food Interaction and all others data.
Olodanrigan is under investigation in clinical trial NCT03297294 (Safety and Efficacy of EMA401 in Patients With Painful Diabetic Neuropathy (PDN)).
| Trade Name | Olodanrigan |
| Generic | Olodanrigan |
| Olodanrigan Other Names | Olodanrigan |
| Type | |
| Formula | C32H29NO5 |
| Weight | Average: 507.586 Monoisotopic: 507.204573038 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Olodanrigan
